Evaluation of Improvement Effect of Traditional Chinese Medicine Acupuncture Therapy on Rheumatoid Arthritis Pain Based on Image Recognition Technology
, e
21 mar 2025
INFORMAZIONI SU QUESTO ARTICOLO
Pubblicato online: 21 mar 2025
Ricevuto: 10 ott 2024
Accettato: 02 feb 2025
DOI: https://doi.org/10.2478/amns-2025-0641
Parole chiave
© 2025 Wenbin Hao et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

Figure 12.

The AUC value of the convolution layer recognition performance
Convolution layer | Characteristic number | Classification performance:AUC | ||||
---|---|---|---|---|---|---|
Mean pooling | Maximization | Variance pooling | Summation | Mean | ||
Zero layer | 61 | 0.59 | 0.57 | 0.54 | 0.57 | 0.57 |
Layer 1 | 125 | 0.61 | 0.55 | 0.58 | 0.59 | 0.60 |
Layer 2 | 248 | 0.64 | 0.60 | 0.60 | 0.55 | 0.58 |
Layer 3 | 498 | 0.67 | 0.71 | 0.65 | 0.57 | 0.64 |
Layer 4 | 498 | 0.64 | 0.57 | 0.59 | 0.60 | 0.59 |
Two groups of patients were treated before and after the esr(mm/1h)
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 67.51±36.71 | 40.23±29.51 |
Control group | 40 | 66.75±35.87 | 51.32±30.53 |
Both groups were treated with CRP(mg/L)
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 22.16±24.08 | 10.72±11.53 |
Control group | 40 | 20.87±23.25 | 11.67±16.01 |
The model data for the test set
Detection value | True value | |
---|---|---|
1:Abnormality | 0:Normal | |
1:Abnormality | 52 | 24 |
0:Normal | 11 | 85 |
Post-treatment DAS28 score
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 6.24±1.13 | 5.23±0.97 |
Control group | 40 | 6.65±2.03 | 5.91±1.65 |
Two groups of subjects were treated before and after the vas score
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 7.25±2.08 | 4.43±1.77 |
Control group | 40 | 6.91±1.92 | 5.16±1.91 |
Data of the two groups of participants
Group | Gender | Age (year) | Course (year) | |
---|---|---|---|---|
Male | Female | |||
Treatment group(n=40) | 23 | 17 | 56.1±9.21 | 12.04±8.12 |
Control group(n=40) | 27 | 13 | 51.42±6.99 | 11.16±8.13 |
P value | 0.845 | 0.091 | 0.711 |
Clinical symptoms of the two groups were compared
Group | Number | VAS score | Stiffness score | DAS28 score |
---|---|---|---|---|
Treatment group | 40 | 8.52±2.41 | 3.42±2.23 | 6.44±0.95 |
Control group | 40 | 8.14±2.82 | 3.62±2.02 | 6.64±1.12 |
P value | 0.41 | 0.85 | 0.51 |
Two groups of patients were treated before and after the test
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 3.27±3.03 | 1.42±1.30 |
Control group | 40 | 3.65±1.83 | 2.58±1.91 |
The two groups of patients were treated with rf(IU/mL)
Group | Number | Pretreatment | After treatment |
---|---|---|---|
Treatment group | 40 | 211.31±251.13 | 134.27±158.03 |
Control group | 40 | 193.87±212.25 | 155.64±181.41 |
Comparison of the subjects’ routine test indexes
Group | Number | RF (IU/Mi) | CRF (mg/L) | ESR (mm/1h) |
---|---|---|---|---|
Treatment group | 40 | 212.71±245.14 | 22.23±24.87 | 67.37±36.87 |
Control group | 40 | 195.87±211.41 | 20.06±22.43 | 66.57±35.85 |
P value | 0.78 | 0.68 | 0.789 |